Replies to post #353964 on Amarin Corp Plc (AMRN)

[couldbebetter]

Zip, Agree 100%. Any BP at anytime could initiate discussions with
AMRN or even make a hostile bid. The Pfizer/HLS deal at a minimum shows
that at least Vascepa is on Pfizer's radar, and should make any other BP
that is remotely interested in AMRN nervous that they could have competition. Of course Pfizer is not going to tell HLS that they
may be interested ultimately in a BO of AMRN, even if they were,
because they would not want to tip their hand. The idea that Pfizer
is only doing this so their Cardio reps can be selling a CVD product is
plausible as a public reason for Pfizer's move. Meowza is correct that
Pfizer has a ton of goodwill in Europe (and of course the US) with its
vaccine being regarded as safe and effective. Imagine what Pfizer could
do with Vascepa for CVD. Pfizer could even claim that they know that
Vascepa not only reduces the risk of events from CVD, but its mode of
action may help to resolve residual inflammation either from the
vaccine or COVID-19 itself, (assuming that is proven.) Vascepa could
be a mega-blockbuster for Pfizer "if" they want it!

[Meowza]

Fresh take on another's idea--Pfizer could be trying to pfuk with a competitor BO attempt. OR Pfizer could simply be locking in a sort of noncommittal BO reservation, if you will.